GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shaanxi Kanghui Pharmaceutical Co Ltd (SHSE:603139) » Definitions » Financial Strength

Shaanxi Kanghui Pharmaceutical Co (SHSE:603139) Financial Strength : 3 (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Shaanxi Kanghui Pharmaceutical Co Financial Strength?

Shaanxi Kanghui Pharmaceutical Co has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.

Warning Sign:

Shaanxi Kanghui Pharmaceutical Co Ltd displays poor financial strength. Usually, this is caused by too much debt for the company.

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is rated on a scale of 1 to 10 and is based on these factors:

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.
2. Debt to revenue ratio. The lower, the better.
3. Altman Z-Score.
4. Other debt related ratios.

A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Shaanxi Kanghui Pharmaceutical Co did not have earnings to cover the interest expense. Shaanxi Kanghui Pharmaceutical Co's debt to revenue ratio for the quarter that ended in Sep. 2024 was 1.25. As of today, Shaanxi Kanghui Pharmaceutical Co's Altman Z-Score is 1.51.


Competitive Comparison of Shaanxi Kanghui Pharmaceutical Co's Financial Strength

For the Drug Manufacturers - Specialty & Generic subindustry, Shaanxi Kanghui Pharmaceutical Co's Financial Strength, along with its competitors' market caps and Financial Strength data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shaanxi Kanghui Pharmaceutical Co's Financial Strength Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shaanxi Kanghui Pharmaceutical Co's Financial Strength distribution charts can be found below:

* The bar in red indicates where Shaanxi Kanghui Pharmaceutical Co's Financial Strength falls into.


;
;

Shaanxi Kanghui Pharmaceutical Co Financial Strength Calculation

GuruFocus Financial Strength Rank measures how strong a company's financial situation is. It is based on these factors

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

1. The debt burden that the company has as measured by its Interest Coverage (current year). The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

Shaanxi Kanghui Pharmaceutical Co's Interest Expense for the months ended in Sep. 2024 was ¥-9.3 Mil. Its Operating Income for the months ended in Sep. 2024 was ¥-18.8 Mil. And its Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥371.1 Mil.

Shaanxi Kanghui Pharmaceutical Co's Interest Coverage for the quarter that ended in Sep. 2024 is

Shaanxi Kanghui Pharmaceutical Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

2. Debt to revenue ratio. The lower, the better.

Shaanxi Kanghui Pharmaceutical Co's Debt to Revenue Ratio for the quarter that ended in Sep. 2024 is

Debt to Revenue Ratio=Total Debt (Q: Sep. 2024 ) / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(325.439 + 371.137) / 555.508
=1.25

3. Altman Z-Score.

Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

The zones of discrimination were as such:

When Z-Score is less than 1.81, it is in Distress Zones.
When Z-Score is greater than 2.99, it is in Safe Zones.
When Z-Score is between 1.81 and 2.99, it is in Grey Zones.

Shaanxi Kanghui Pharmaceutical Co has a Z-score of 1.51, indicating it is in Distress Zones. This implies bankrupcy possibility in the next two years.

Warning Sign:

Altman Z-score of 1.51 is in distress zone. This implies bankruptcy possibility in the next two years.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shaanxi Kanghui Pharmaceutical Co  (SHSE:603139) Financial Strength Explanation

The rank is rated on a scale of 1 to 10. A higher score indicates a stronger financial position, with companies rated 7 or above considered financially stable and unlikely to face distress. Conversely, a score of 3 or below suggests potential financial difficulties, indicating a higher risk of distress.

Shaanxi Kanghui Pharmaceutical Co has the Financial Strength Rank of 3. It displays poor financial strength and is likely in financial distress. Usually this is caused by too much debt for the company.


Shaanxi Kanghui Pharmaceutical Co Financial Strength Related Terms

Thank you for viewing the detailed overview of Shaanxi Kanghui Pharmaceutical Co's Financial Strength provided by GuruFocus.com. Please click on the following links to see related term pages.


Shaanxi Kanghui Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 36, Yanzhi Road, Qindu District, Shaanxi Province, Xianyang, CHN, 71200
Shaanxi Kanghui Pharmaceutical Co Ltd is engaged in research, development, production and sales of pharmaceutical products. It manufactures tablets, capsules, granules, oral liquids for respiratory and cold diseases, gynecological, orthopedic diseases.
Executives
Yang Jin Director

Shaanxi Kanghui Pharmaceutical Co Headlines

No Headlines